Michael Korenjak

1.7k total citations
28 papers, 1.2k citations indexed

About

Michael Korenjak is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Michael Korenjak has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Michael Korenjak's work include Cancer-related Molecular Pathways (12 papers), Genomics and Chromatin Dynamics (8 papers) and Epigenetics and DNA Methylation (7 papers). Michael Korenjak is often cited by papers focused on Cancer-related Molecular Pathways (12 papers), Genomics and Chromatin Dynamics (8 papers) and Epigenetics and DNA Methylation (7 papers). Michael Korenjak collaborates with scholars based in United States, Germany and France. Michael Korenjak's co-authors include Alexander Brehm, Jiří Zavadil, Nicholas J. Dyson, Ulrich K. Binné, Barbie Taylor‐Harding, Rein Aasland, Olivier Nolan-Stevaux, John S. Satterlee, Helen White‐Cooper and Nick Dyson and has published in prestigious journals such as Cell, Nucleic Acids Research and Genes & Development.

In The Last Decade

Michael Korenjak

28 papers receiving 1.2k citations

Peers

Michael Korenjak

ONCOL

Thomas Caspari United Kingdom

H. Gut Switzerland

Tracey C. Fleischer United States

Young‐Han Song South Korea

Ramars Amanchy India

Benjamin Barré France

Susanne Lienhard Switzerland

Margaret M. Kasten United States

Karin Flick United States

Christopher Flynn United States

Thomas Caspari United Kingdom

Michael Korenjak

1.5k ×1.7

352 ×1.0

ONCOL

328 ×1.4

334 ×1.9

209 ×1.3

Citations per year, relative to Michael Korenjak Michael Korenjak (= 1×) peers Thomas Caspari

Countries citing papers authored by Michael Korenjak

Since Specialization

Citations

This map shows the geographic impact of Michael Korenjak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Korenjak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Korenjak more than expected).

Fields of papers citing papers by Michael Korenjak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Korenjak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Korenjak. The network helps show where Michael Korenjak may publish in the future.

Co-authorship network of co-authors of Michael Korenjak

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Korenjak. A scholar is included among the top collaborators of Michael Korenjak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Korenjak. Michael Korenjak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Korenjak, Michael, et al.. (2022). Aristolochic acid-associated cancers: a public health risk in need of global action. Nature reviews. Cancer. 22(10). 576–591. 65 indexed citations

Barupal, Dinesh Kumar, Mary K. Schubauer‐Berigan, Michael Korenjak, Jiří Zavadil, & Kathryn Z. Guyton. (2021). Prioritizing cancer hazard assessments for IARC Monographs using an integrated approach of database fusion and text mining. Environment International. 156. 106624–106624. 7 indexed citations

Claeys, Liesel, Chiara Romano, Karl De Ruyck, et al.. (2020). Mycotoxin exposure and human cancer risk: A systematic review of epidemiological studies. Comprehensive Reviews in Food Science and Food Safety. 19(4). 1449–1464. 174 indexed citations

Korenjak, Michael, et al.. (2020). Experimental investigations of carcinogen-induced mutation spectra: Innovation, challenges and future directions. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 853. 503195–503195. 2 indexed citations

Ng, Alvin Wei Tian, Maude Ardin, Mona I. Churchwell, et al.. (2019). Experimental and pan-cancer genome analyses reveal widespread contribution of acrylamide exposure to carcinogenesis in humans. Genome Research. 29(4). 521–531. 59 indexed citations

Ardin, Maude, Annette Weninger, Sarah Barrin, et al.. (2017). Modeling cancer driver events in vitro using barrier bypass-clonal expansion assays and massively parallel sequencing. Oncogene. 36(43). 6041–6048. 8 indexed citations

Morris, Robert, Michael Korenjak, Myriam Boukhali, et al.. (2017). E2F/DP Prevents Cell-Cycle Progression in Endocycling Fat Body Cells by Suppressing dATM Expression. Developmental Cell. 43(6). 689–703.e5. 15 indexed citations

Korenjak, Michael, Eun‐Jeong Kwon, Robert Morris, et al.. (2014). dREAM co-operates with insulator-binding proteins and regulates expression at divergently paired genes. Nucleic Acids Research. 42(14). 8939–8953. 18 indexed citations

Miles, Wayne, Michael Korenjak, Lyra Griffiths, et al.. (2014). Post‐transcriptional gene expression control by NANOS is up‐regulated and functionally important in pR b‐deficient cells. The EMBO Journal. 33(19). 2201–2215. 22 indexed citations

10.

Ji, Jun‐Yuan, et al.. (2012). In VivoRegulation of E2F1 by Polycomb Group Genes inDrosophila. G3 Genes Genomes Genetics. 2(12). 1651–1660. 14 indexed citations

11.

Korenjak, Michael, Endre Anderssen, Sridhar Ramaswamy, Johnathan R. Whetstine, & Nicholas J. Dyson. (2012). RBF Binding to both Canonical E2F Targets and Noncanonical Targets Depends on Functional dE2F/dDP Complexes. Molecular and Cellular Biology. 32(21). 4375–4387. 47 indexed citations

12.

Herr, Anabel, Michelle S. Longworth, Jun‐Yuan Ji, et al.. (2012). Identification of E2F target genes that are rate limiting for dE2F1‐dependent cell proliferation. Developmental Dynamics. 241(11). 1695–1707. 4 indexed citations

13.

Korenjak, Michael, et al.. (2011). Rb deficiency during Drosophila eye development deregulates EMC, causing defects in the development of photoreceptors and cone cells. Journal of Cell Science. 124(24). 4203–4212. 8 indexed citations

14.

Gao, Daming, Hiroyuki Inuzuka, Michael Korenjak, et al.. (2009). Cdh1 Regulates Cell Cycle through Modulating the Claspin/Chk1 and the Rb/E2F1 Pathways. Molecular Biology of the Cell. 20(14). 3305–3316. 52 indexed citations

15.

Schmit, Fabienne, Michael Korenjak, Claudia Franke, et al.. (2007). LINC, a Human Complex That is Related to pRB-Containing Complexes in Invertebrates Regulates the Expression of G₂/M Genes. Cell Cycle. 6(15). 1903–1913. 157 indexed citations

16.

Korenjak, Michael & Alexander Brehm. (2006). The Retinoblastoma Tumour Suppressor in Model Organisms-New Insights from Flies and Worms. Current Molecular Medicine. 6(7). 705–711. 11 indexed citations

17.

Korenjak, Michael & Alexander Brehm. (2005). E2F–Rb complexes regulating transcription of genes important for differentiation and development. Current Opinion in Genetics & Development. 15(5). 520–527. 121 indexed citations

18.

Bouazoune, Karim, Michael Korenjak, & Alexander Brehm. (2004). The dosage-compensation complex in flies and humans.. Genome Biology. 5(11). 352–352. 1 indexed citations

19.

Korenjak, Michael, Barbie Taylor‐Harding, Ulrich K. Binné, et al.. (2004). Native E2F/RBF Complexes Contain Myb-Interacting Proteins and Repress Transcription of Developmentally Controlled E2F Target Genes. Cell. 119(2). 181–193. 242 indexed citations

20.

Sutcliffe, Josephine E., Michael Korenjak, & Alexander Brehm. (2003). Tumour suppressors—a fly's perspective. European Journal of Cancer. 39(10). 1355–1362. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact